Haemolysis – Causes, Symptoms and Treatment
Haemolysis is the breakdown of red blood cells, releasing haemoglobin into the bloodstream. It can range from a normal process to a life-threatening condition.
Things worth knowing about "Haemolysis"
Haemolysis is the breakdown of red blood cells, releasing haemoglobin into the bloodstream. It can range from a normal process to a life-threatening condition.
What is Haemolysis?
Haemolysis refers to the destruction or breakdown of red blood cells (erythrocytes), which causes the release of their oxygen-carrying protein, haemoglobin, into the surrounding plasma or bloodstream. A small degree of haemolysis is a normal physiological process, as ageing red blood cells are naturally removed after approximately 120 days. However, when haemolysis becomes accelerated or pathological, it can overwhelm the body's compensatory mechanisms and lead to haemolytic anaemia -- a reduction in healthy red blood cells that impairs oxygen delivery to tissues.
Causes
Haemolysis can be classified based on whether the cause originates within the red blood cell itself (intrinsic/corpuscular haemolysis) or from external factors (extrinsic/extracorpuscular haemolysis).
Intrinsic (Corpuscular) Causes
- Inherited conditions: Sickle cell disease, thalassaemia, hereditary spherocytosis
- Enzyme deficiencies: Glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)
- Haemoglobinopathies: Structural abnormalities of haemoglobin
Extrinsic (Extracorpuscular) Causes
- Immune-mediated: Autoimmune haemolytic anaemia, blood transfusion reactions (ABO incompatibility)
- Infections: Malaria, certain bacterial infections (e.g., Clostridium perfringens)
- Mechanical causes: Prosthetic heart valves, microangiopathic haemolytic anaemia (e.g., thrombotic thrombocytopenic purpura, TTP)
- Toxic causes: Snake venoms, certain drugs (e.g., dapsone), industrial chemicals
- Physical causes: Severe burns, extreme osmotic stress
Symptoms
The clinical presentation of haemolysis depends on the rate and severity of red blood cell destruction. Common signs and symptoms include:
- Anaemia symptoms: Pallor, fatigue, weakness, shortness of breath, rapid heart rate
- Jaundice (icterus): Yellowing of the skin and whites of the eyes due to elevated bilirubin levels (a breakdown product of haemoglobin)
- Dark urine: Caused by free haemoglobin in the urine (haemoglobinuria) or urobilinogen
- Enlarged spleen (splenomegaly): The spleen enlarges as it filters increased numbers of damaged red blood cells
- Gallstones: Excess bilirubin from haemolysis can precipitate as pigment gallstones
Acute severe haemolysis can result in a haemolytic crisis, which is a medical emergency requiring immediate intervention.
Diagnosis
Diagnosis is established through clinical assessment and laboratory testing:
- Full blood count (FBC): Low haemoglobin (anaemia) and elevated reticulocyte count (young red blood cells indicating increased bone marrow production)
- Serum markers: Elevated indirect bilirubin, reduced or undetectable haptoglobin (a protein that binds free haemoglobin and is depleted during haemolysis)
- Lactate dehydrogenase (LDH): Elevated due to release from lysed cells
- Direct antiglobulin test (DAT / Coombs test): Detects antibodies on red blood cells in immune-mediated haemolysis
- Blood film (peripheral smear): Microscopic evaluation for abnormal red cell morphology (e.g., sickle cells, spherocytes, schistocytes/fragmented cells)
- Urine dipstick: Detects haemoglobinuria
Treatment
Treatment of haemolysis is directed at the underlying cause:
- Immune haemolytic anaemia: Corticosteroids, immunosuppressants, intravenous immunoglobulins, and in selected cases splenectomy (surgical removal of the spleen)
- Infection-related haemolysis (e.g., malaria): Targeted antimicrobial or antiparasitic therapy
- Toxic haemolysis: Removal or discontinuation of the causative agent, supportive care
- Hereditary haemolytic conditions: Symptomatic management; in severe cases blood transfusions or bone marrow transplantation
- Acute severe haemolysis: Emergency management including fluid resuscitation, transfusion support, and intensive care monitoring
References
- Longo, D.L. et al. - Harrison's Principles of Internal Medicine, 21st Edition. McGraw-Hill, 2022.
- Barcellini, W. & Fattizzo, B. - Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Monitoring of Hemolytic Anemia. Disease Markers, 2015. PubMed PMID: 26609218.
- World Health Organization (WHO) - Sickle-cell disease and other haemoglobin disorders. Available at: https://www.who.int (accessed 2024).
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMacronutrients
Portion control
Food craving
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Haemolysis-en